Capsules Indicated News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Misty Lee January 22, 2021 TherapeuticsMD Inc. [NASDAQ: TXMD] slipped around -0.06 points on Friday, while shares priced at $1.17 at the close of the session, down -4.88%. The company report on April 9, 2021 that TherapeuticsMD and Theramex Announce the Approval of BIJUVE® Capsules Indicated for Hormone Replacement Therapy in the United Kingdom and Under the Trade Name BIJUVA® in Belgium. TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women’s healthcare company, and Theramex, a dedicated women’s health company, announced that BIJUVE® has received approval from th...

Misty Lee August 20, 2020 TherapeuticsMD Inc. [NASDAQ: TXMD] gained 0.86% or 0.01 points to close at $1.17 with a heavy trading volume of 8066832 shares. The company report on April 9, 2021 that TherapeuticsMD and Theramex Announce the Approval of BIJUVE® Capsules Indicated for Hormone Replacement Therapy in the United Kingdom and Under the Trade Name BIJUVA® in Belgium. TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women’s healthcare company, and Theramex, a dedicated women’s health company, announced that BIJUVE® has received approval from the Medicines and He...

Caleb Clifford November 6, 2020 TherapeuticsMD Inc. [NASDAQ: TXMD] plunged by -$0.05 during the normal trading session on Tuesday and reaching a high of $1.285 during the day while it closed the day at $1.23. The company report on April 9, 2021 that TherapeuticsMD and Theramex Announce the Approval of BIJUVE® Capsules Indicated for Hormone Replacement Therapy in the United Kingdom and Under the Trade Name BIJUVA® in Belgium. TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women’s healthcare company, and Theramex, a dedicated women’s health company, announced that B...